Art

J-GLOBAL ID：201902206094181387   Reference number：19S0401475

Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells

Author (11)： Motoshima, Takanobu (Department of Urology, Graduate School of Medical Sciences, Kumamoto University) ,  Motoshima, Takanobu (Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University) ,  Maeda, Yoshihiro (Department of Urology, Graduate School of Medical Sciences, Kumamoto University) ,  Tanoue, Kenichiro (Department of Urology, Graduate School of Medical Sciences, Kumamoto University) ,  Kawano, Yoshiaki (Department of Urology, Graduate School of Medical Sciences, Kumamoto University) ,  Eto, Masatoshi (Department of Urology, Graduate School of Medical Sciences, Kumamoto University) ,  Komohara, Yoshihiro (Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University) ,  Horlad, Hasita (Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University) ,  Takeya, Motohiro (Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University) ,  Takeuchi, Ario (Department of Urology, Graduate School of Medical Sciences, Kyusyu University) ,  Harada, Mamoru (Department of Immunology, Shimane University Faculty of Medicine)
Material： Oncology Reports
Volume： 33  Issue： 6  Page： 2947-2953  Publication year： 2015 
JST Material Number： SCOPUS  ISSN： 1021-335X  CODEN： OCRPE 
Country of issue： Greece (GRC)  Language： English (EN)

Terms in the title (1)： Cancer